The chances of a sale of Life Technologies (LIFE) are reportedly diminishing following the 30% increase in the company's share price this year, which is mainly because of its January announcement ...
Read the rest of this article on SeekingAlpha.com: SA Currents
Related Videos
-
Will Life Sciences Firms Fall Off the Fiscal Cliff?Even if the NIH is drastically cut, we don't see a doomsday scenario for these companies, and some of the industry's stronger players are now trading at attractive valuations.
-
Three Big Themes Can Spell Opportunity for InvestorsIncreased life sciences funding, declining consumer charge-offs, and underappreciated earnings power at big banks have made some ripe picks for investors.
-
Low Volatility vs High Dividend: Which One Is Better?Morningstar ETF Invest Conference panelists discuss the similarities, differences, and appeal of these two strategies in today's low-growth, low-return, and high-volatility market.
-
Gundlach on 'Too Big to Fail' Asset ManagersDoubleLine CEO, CIO, and portfolio manager Jeffrey Gundlach says if Citigroup was too big to fail, then so much greater is the risk for asset managers operating with multiples of that market cap .